Home Biomarkers COVID 19 IgM

COVID 19 IgM

COVID Biomarker

Sample Needed

Collection Type: Blood

Body System

Related System: COVID

Overview

COVID-19 IgM is an immunoglobulin M antibody test that detects early humoral immune response to SARS-CoV-2 infection. The assay measures IgM class antibodies directed against viral proteins; IgM typically appears within about 5–10 days after infection onset, peaks in the second to third week, and then declines. A positive IgM suggests recent or ongoing infection but does not distinguish active replication from recent exposure; polymerase chain reaction (PCR) is needed to confirm active infection. Indications include recent symptoms (fever, cough, loss of taste/smell, respiratory symptoms) or known exposure. Antibody responses vary with age, immune status, prior vaccination, and comorbidities elderly or immunocompromised patients may have delayed/attenuated IgM responses.

People also test for

Test Preparation

No special preparation is required

Why Do I Need This Test

Profile: included in the COVID antibody/serology profile.
Symptoms: recent respiratory illness, fever, anosmia, or known exposure when PCR is negative or unavailable.
Diagnoses/monitoring: suggests recent SARS‑CoV‑2 infection, helps with exposure assessment and epidemiology.
Causes of abnormal levels: recent infection (high), early testing or immunodeficiency (low/negative), cross‑reactivity or assay interference (false positive).
Biological meaning: positive IgM indicates recent immune response; absent IgM may mean no infection or testing too early/late.
Lifestyle/family history: immunosuppressive therapy, recent blood product exposure, or familial immunodeficiency may affect results.

Run our symptom checker to see if this test is right for you

Symptom Checker

Understanding Test Results

Index <1.0: Negative/non‑reactive no detectable IgM; suggests no recent infection or testing performed before seroconversion or in immunosuppressed individuals.
Correlate with symptoms and PCR if acute infection suspected.
Index ~1.0–1.9: Equivocal/low‑positive borderline result; repeat testing in 3–7 days and/or perform PCR to clarify.
Index ≥1.0 (commonly used positive cutoff) and especially ≥2.0: Reactive/positive consistent with recent or ongoing SARS‑CoV‑2 exposure; higher values generally indicate stronger IgM response but do not prove active viral replication.
Confirm with PCR if clinical suspicion of active infection.
Persistently positive IgM weeks after illness may reflect prolonged serologic response or assay cross‑reactivity (e.g., other coronaviruses, rheumatoid factor) and should be interpreted with clinical context.

Normal Range

Index <1.0 (Negative non‑reactive)

FAQs

Q: How long does IgM stay positive in COVID?

A: IgM antibodies to SARS-CoV-2 typically appear about 5–10 days after symptom onset, peak around 2–3 weeks, and generally decline over several weeks. In most people IgM becomes undetectable by about 6–8 weeks, though levels can persist longer (occasionally up to 2–3 months). Timing varies by individual, disease severity, and test sensitivity, so results must be interpreted cautiously.

Q: What are the IgM levels after Covid?

A: IgM antibodies to SARS‑CoV‑2 usually appear about 5–10 days after infection, peak at roughly 2–3 weeks, then decline over several weeks and often become undetectable by 6–12 weeks. Levels vary by individual, illness severity, vaccination status and the antibody assay used; IgG antibodies generally persist much longer. Quantitative results differ between labs and positive/negative cutoffs depend on the test.

Q: How long is IgM positive for?

A: IgM antibodies indicate recent or acute infection. They typically appear within about 3–7 days after exposure, peak around 2–3 weeks, and are usually detectable for roughly 4–12 weeks. In some infections or individuals they may decline sooner or persist for several months, so results should be interpreted alongside symptoms, exposure timing, and follow-up or confirmatory testing.

Q: What does a positive COVID-19 IgM mean?

A: A positive COVID‑19 IgM antibody usually indicates a recent or early SARS‑CoV‑2 infection, as IgM appears in the first days to weeks after exposure. It does not prove immunity and should be interpreted with symptoms, exposure history and a diagnostic PCR; false positives and cross‑reactivity can occur. Repeat testing or molecular confirmation is recommended to establish active infection.

Q: What is the difference between COVID IgM and IgG?

A: IgM and IgG are different antibody types against SARS‑CoV‑2. IgM appears first, usually within days–weeks of infection, indicating a recent or active response and then wanes after a few weeks. IgG arises later (often 2–3 weeks), indicating past infection or developed immunity and tends to persist longer. Antibody presence doesn’t guarantee full protection, and timing affects test accuracy.

Q: Can you have COVID IgM positive but PCR negative?

A: Yes. An IgM-positive but PCR-negative result can occur. IgM antibodies suggest recent immune response, while PCR detects current viral RNA; PCR may be negative if the virus is already cleared, viral load is below detection, or sampling was inadequate. False-positive IgM (cross-reactivity) or lab error can also cause discordance. Correlate with symptoms and exposure and consider repeat PCR/serology or clinical advice.